CD4 and schistosomiasis: Studies addressing immunologic mechanisms triggered by the most promising vaccine antigens for schistosomiasis have revealed CD4+ T cell responses, and IFN-γ production, as outcomes closely related to protection against the parasite infection (21, 79, 80).